Temple spinoff Express Cells secures first patent for gene-editing technology

A three-year-old Philadelphia genetic engineering company spun out of Temple University has secured its first patent for its core gene-editing technology. ExpressCells was awarded the U.S. patent for its "Fast-HDR" gene editing technology, developed to create advanced cell lines for drug discovery. The inventor on the technology covered by the patent is Dr. Oscar Perez Leal, an assistant professor at the Temple University School of Pharmacy and a c o-founder ExpressCells. He is also a scientific…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news